Azuvas 10- F

Composition:

A fixed-dose combination of Rosuvastatin and Micronised Fenofibrate
Each film-coated tablet contains:
- Rosuvastatin 10 mg
- Fenofibrate (micronised) 160 mg

Azuvas 10 F: Effect on lipid parameters

Parameters	Rosuvastatin 10 mg	Fenofibrate 160 mg	Azuvas 10 F
LDL	- 52%	- 19.1%	Additive
TG	- 37%	- 28.1%	Additive
HDL	+ 14%	+ 11%	Additive

Fenofibrate – Non- Lipid Actions

Reductioninserumuricacidlevels
Loweringofserumfibrinogenlevels
Fenofibrateimprovesinsulinsensitivity

Azuvas 10 F : Indications

Combined/mixed hyperlipidemia
Diabetic Dyslipidemia
Patients with CAD not able to achieve goals of therapy with statin monotherapy

Azuvas 10 F : Dosage

The recommended dosage is one tablet, once daily either morning or evening
should be given with meals, thereby optimizing the bioavailability of Fenofibrate